Sensus Healthcare, Inc.

SRTS

US81728J1097

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-11 pm EDT			5-day change	1st Jan Change
5.69 ^USD	+5.18%		+12.23%	+141.10%

May. 31	Sensus Healthcare, Inc. Announces Resignation of John Heinrich from the Board of Directors	CI
May. 10	Top MIdday Gainers	MT

Sensus Healthcare, Inc. Provides Earnings Guidance for the Fourth Quarter of Fiscal 2020

November 05, 2020 at 04:30 pm EST

Sensus Healthcare, Inc. provided earnings guidance for the fourth quarter of fiscal 2020. The company expects a better financial performance in the fourth quarter.

Latest news about Sensus Healthcare, Inc.

Sensus Healthcare, Inc. Announces Resignation of John Heinrich from the Board of Directors	May. 31	CI
Top MIdday Gainers	May. 10	MT
Wall Street Set to Extend Gains on Thursday's Higher-Than-Expect Jobless Claims Report, Lifting US Equity Futures Pre-Bell	May. 10	MT
Top Premarket Gainers	May. 10	MT
Earnings Flash (SRTS) SENSUS HEALTHCARE Reports Q1 Revenue $10.7M	May. 09	MT
Transcript : Sensus Healthcare, Inc., Q1 2024 Earnings Call, May 09, 2024	May. 09
Sensus Healthcare, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
Sensus Healthcare Sells First Superficial Radiotherapy System in Asia	May. 06	MT
Transcript : Sensus Healthcare, Inc., Q4 2023 Earnings Call, Feb 08, 2024	Feb. 08
Sensus Healthcare, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 08	CI
Earnings Flash (SRTS) SENSUS HEALTHCARE Posts Q4 Revenue $12.6M, vs. Street Est of $12.1M	Feb. 08	MT
Sensus Healthcare Announces Directors Changes	Feb. 01	CI
Sensus Healthcare, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2023	Jan. 23	CI
Sensus Healthcare, Inc. Appoints Michael Sardano as A Director, Effective February 1, 2024	Jan. 18	CI
Tranche Update on Sensus Healthcare, Inc.'s Equity Buyback Plan announced on August 8, 2023.	Nov. 13	CI
Transcript : Sensus Healthcare, Inc., Q3 2023 Earnings Call, Nov 09, 2023	Nov. 09
Earnings Flash (SRTS) SENSUS HEALTHCARE Posts Q3 Revenue $3.9M	Nov. 09	MT
Sensus Healthcare, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Sensus Healthcare to Showcase its Full Line of Cutting-Edge Superficial Radiotherapy Devices for the Treatment of Non-melanoma Skin Cancer at ASTRO 2023 in San Diego	23-09-26	CI
Sensus Healthcare, Inc.(NasdaqCM:SRTS) dropped from S&P Global BMI Index	23-09-18	CI
Sensus Healthcare, Inc. Enters into A Credit Agreement with Comerica Bank	23-09-14	CI
Tranche Update on Sensus Healthcare, Inc.'s Equity Buyback Plan announced on March 9, 2022.	23-08-11	CI
Sensus Healthcare Launches $3 Million Stock Buyback Program; Shares Surge 15% Midday	23-08-08	MT
Sensus Healthcare, Inc. announces an Equity Buyback for $3 million worth of its shares.	23-08-08	CI
Sensus Healthcare, Inc. authorizes a Buyback Plan.	23-08-07	CI

Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100+ offer remote diagnostics solutions, including operation tracking.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-07-31 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Sensus Healthcare, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

5.69 USD

Average target price

10 USD

Spread / Average Target

+75.75%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
SENSUS HEALTHCARE, INC.	+141.10%	93.27M
SARTORIUS AG	-28.45%	16.36B
QUIDELORTHO CORPORATION	-57.29%	2.11B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+13.19%	1.79B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-15.17%	1.41B
BIOTAGE AB	+28.50%	1.29B
REVENIO GROUP OYJ	+6.26%	861M
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-33.05%	770M
CONTEC MEDICAL SYSTEMS CO.,LTD	-36.55%	725M
CELLAVISION AB	+29.72%	615M

Medical Diagnostic & Testing Equipment